Bacterial Skin Infections

Vulvovaginal diseases commonly are inadequately diagnosed and treated. This article discusses the important role dermatologists play in identifying irregular presentations, recognizing skin problems, and addressing itch, pain, and inflammation.

In atopic dermatitis, the stratum corneum of patients appears to have alterations that predispose them to colonization and invasion by various bacteria. Retapamulin appears to be a much needed antimicrobial option for treating the atopic dermatitis population due to their common carriage of bacterial pathogens.

Young adult populations (18-25 years of age) throughout the world have latched onto the mainstream trend of body piercing. Best health care practices for these individuals involves the knowledge of proper procedural techniques, postsite care, common complications, and treatment modalities.

Cuts and scrapes are rarely talked about, but a very common injury that everyone has experience with. This article explains the various problems like infection, healing, and scars, and how to manage these.

Commensal bacteria that live on the skin can sometimes cause superficial infection, leading to disease. This article discusses three common infections by commensal bacteria, and how to manage infection.

Staph aureus can cause several common bacterial infections like impetigo, ecthyma, and folliculitis. The most common infections and their proper management are discussed.

MRSA OR Methicillin resistant staphylococcus aureus is a source of worry for health practitioners and patients alike. This article is a practical guide to managing MRSA and infection control.

Strep pyogenes is responsible for many infections. This article discusses various skin infections that are attributed to this bacteria, and the appropriate treatment and management of each of these infections.

Bacterial skin infections are common. This article discusses a range of topics including therapies, the problem of bacterial resistance, folliculitis, and other common infections.

Recognition and appropriate treatment of these common bacterial skin infections, while at times challenging, can be very rewarding for both the physician and the patient. Selecting the right therapy from the beginning should help minimize complications, reduce the number of hospitalizations, and may also help reduce the climbing incidence of bacterial resistance.

Moxifloxacin (Avelox®, Bayer), which is available for oral administration, is a broad-spectrum synthetic antimicrobial agent with excellent Gram-positive activity and good Gram-negative activity. The US FDA recently approved this drug for the treatment of bacterial skin infections.

Antibiotic prophylaxis aims to prevent wound infections and provide adequate antibiotic cover for patients with prostheses or at risk for endocarditis. Most recommendations are based spread of risk factors may not accurately predict the risks for patients. A case for prophylaxis is made.